Back to Search Start Over

Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.

Authors :
Mejia-Chew, Carlos
Carver, Peggy L
Rutjanawech, Sasinuch
Camargo, Luis F Aranha
Fernandes, Ruan
Belga, Sara
Daniels, Shay-Anne
Müller, Nicolas J
Burkhard, Sara
Theodoropoulos, Nicole M
Postma, Douwe F
Duijn, Pleun J van
Fariñas, María Carmen
González-Rico, Claudia
Hand, Jonathan
Lowe, Adam
Bodro, Marta
Vanino, Elisa
Cruz, Ana Fernández
Ramos, Antonio
Source :
Clinical Infectious Diseases; 2/1/2023, Vol. 76 Issue 3, pe995-e1003, 9p
Publication Year :
2023

Abstract

Background Risk factors for nontuberculous mycobacteria (NTM) infections after solid organ transplant (SOT) are not well characterized. Here we aimed to describe these factors. Methods Retrospective, multinational, 1:2 matched case-control study that included SOT recipients ≥12 years old diagnosed with NTM infection from 1 January 2008 to 31 December 2018. Controls were matched on transplanted organ, NTM treatment center, and post-transplant survival greater than or equal to the time to NTM diagnosis. Logistic regression on matched pairs was used to assess associations between risk factors and NTM infections. Results Analyses included 85 cases and 169 controls (59% male, 88% White, median age at time of SOT of 54 years [interquartile range {IQR} 40–62]). NTM infection occurred in kidney (42%), lung (35%), heart and liver (11% each), and pancreas transplant recipients (1%). Median time from transplant to infection was 21.6 months (IQR 5.3–55.2). Most underlying comorbidities were evenly distributed between groups; however, cases were older at the time of NTM diagnosis, more frequently on systemic corticosteroids and had a lower lymphocyte count (all P <.05). In the multivariable model, older age at transplant (adjusted odds ratio [aOR] 1.04; 95 confidence interval [CI], 1.01–1.07), hospital admission within 90 days (aOR, 3.14; 95% CI, 1.41–6.98), receipt of antifungals (aOR, 5.35; 95% CI, 1.7–16.91), and lymphocyte-specific antibodies (aOR, 7.73; 95% CI, 1.07–56.14), were associated with NTM infection. Conclusions Risk of NTM infection in SOT recipients was associated with older age at SOT, prior hospital admission, receipt of antifungals or lymphocyte-specific antibodies. NTM infection should be considered in SOT patients with these risk factors. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10584838
Volume :
76
Issue :
3
Database :
Complementary Index
Journal :
Clinical Infectious Diseases
Publication Type :
Academic Journal
Accession number :
161829756
Full Text :
https://doi.org/10.1093/cid/ciac608